期刊文献+

559例皮肤痣样病变的临床与病理分析 被引量:1

Clinicopathologic Characteristics of 559 Cases of Dermal Nevus
原文传递
导出
摘要 目的探讨皮肤痣样病变的临床病理特征与免疫组织化学特点,为鉴别诊断提供较为可靠的参考依据。方法选择559份皮肤痣样病变的临床病例,观察其临床病理特征,并行免疫组织化学染色。结果所有病例中诊断良性黑色素细胞肿瘤480例,黑色素瘤47例,皮脂腺痣21例,表皮痣11例。免疫组织化学显示S-100、MelanA、VIM在良恶性皮肤痣样病变中均弥漫表达,而HMB45和CyclinD1在良恶性皮肤痣样病变中的表达程度和分布上有差异,B淋巴细胞瘤-2基因(B-cell lymphoma,Bcl-2)、P16、Ki-67和P53在恶性中的表达强于良性。结论 HMB45、CyclinD1、Bcl-2、P16、Ki-67和P53等的免疫组织化学染色存在差异,可以作为鉴别诊断的重要参考。 Objective To investigate the clinical and pathological features,immunohistochemical features and differ- ential diagnosis method of dermal nevus. Methods The clinical and pathological features and immunohistochemistry ex- amination of 559 dermal nevus cases were collected and analyzed. Results A total of 559 cases of dermal nevus were diag- nosed as melanocytic tumor with 480 cases, melanoma with 47 cases, nevus sebaceous with 21 cases and epidermal nevi with 11 cases. Immunohistochemi stry showed that S-100, MelanA, VIM were diffuse expression in benign and malignant dermal nevus. And the expression of HMB45 and CyclinD1 were difference in the degree and distribution. The expression of B-cell lymphoma(Bcl-2), P16, Ki-67, and P53 were stronger in malignant than benign. Conclusion The irnmunohisto- chemical examination of HMIM5, CyclinD1, Bcb2, P16, Ki-67 and P53 have differences, can serve as an important reference for the diagnostic and differential diagnosis.
出处 《华南国防医学杂志》 CAS 2016年第4期226-230,共5页 Military Medical Journal of South China
关键词 皮肤痣样病变 黑色素细胞瘤 黑色素瘤 免疫表型 鉴别诊断 Dermal nevus Melanocytic tumor Melanoma Immunological phenotype Differential diagnostic
  • 相关文献

参考文献16

  • 1Leboit PE,Burg G,Weedon D,等.皮肤肿瘤病理学和遗传学[M].廖松林主译.北京:人民卫生出版社,2006.20.
  • 2麦中基,卡隆赫,格兰特尔.皮肤病理学(上下卷)[M].朱学骏,孙建方,译.3版.北京:北京大学医学出版社,2007:1252-1253,1260.
  • 3博洛格尼,乔伊佐,拉皮尼.皮肤病学[M].2版.朱学骏译.北京:北京大学医学出版社,2011:237-254.
  • 4KoCJ,BarrRJ.皮肤病理快速诊断图谱[M].顾军,毕新岭,译,2版.北京:人民卫生出版社,2013:123.
  • 5田艳丽,王文岭,刘静洋,常冬青,谷廷敏,杨蓉娅.色素痣样皮损381例的临床与组织病理分析[J].中国美容医学,2012,21(9):1554-1555. 被引量:7
  • 6BusamKJ.皮肤病理学[M3.黄勇,薛德彬,黄文斌,译.北京:北京科学技术出版社,2015:473-474.
  • 7刘彤华.诊断病理学[M].3版.北京:人民卫生出版社,2013:642-721.
  • 8Martin V, Banff S, Bordoni A, et al. Presence of cytogenetic abnor malities in Spitz naevi: a diagnostic challenge for fluorescence in- situ hybridization analysis [J]. Histopathology, 2012, 60 (2) : 336- 346.
  • 9郭芳,普文静,康晓静.新疆地区58例恶性黑色素瘤临床及病理初步分析[J].皮肤病与性病,2012,34(3):133-134. 被引量:3
  • 10Rosai J.阿克曼外科病理学[M].9版.北京:北京大学医学出版社,2006:625-9.

二级参考文献56

  • 1马雷,李杨.S100A4蛋白在甲状腺癌中的表达和意义[J].中国医药生物技术,2007,2(1):41-45. 被引量:1
  • 2张徽,米粲,李园园.HMB45,S—100蛋白,Vimentin在原发性恶性黑色素瘤中的表达及意义[J].重庆医科大学学报,1996,21(3):206-208. 被引量:3
  • 3韩睿,程浩,朱可建.恶性黑素瘤38例临床分析[J].中国皮肤性病学杂志,2007,21(8):477-478. 被引量:5
  • 4Gown AM,Vogel AM,Hoak D,et al.Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes[J].Am J Pathol,1986,123(2):195.
  • 5Denat L,Larue L.Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor[J].Bull Cancer,2007,94(1):81.
  • 6King R,Googe PB,Weilbaecher KN,et al.Microphthalmia transcription factor expression in cutaneous benign,malignant melanocytic,and nonmelanocytic tumors[J].Am J Surg Pathol,2001,25(1):51.
  • 7Granter SR,Weilbaecher KN,Quigley C,et al.Role for microphthalmia transcription factor in the diagnosis of metastatic malignant melanoma[J].Appl Immunohistochem Mol Morphol,2002,10(1):47.
  • 8Miettinen M,Fernandez M,Franssila K,et al.Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma:comparison with four other melanoma markers[J].Am J Surg Pathol,2001,25(2):205.
  • 9邓军,黄惠,程良金,叶庆佾.皮肤色素痣不同治疗方法疗效分析比较[J].中国美容医学,2007,16(8):1094-1096. 被引量:29
  • 10Meyer P, Sergi C, Garbe C. Polymorphisms of the BRAF gene predispose males to maligant melanoma[J]. Carcinog, 2003, 2(1): 7.

共引文献61

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部